Complex Regional Pain Syndrome emerges following injury, surgery, or sometimes without clear precipitant, characterised by disproportionate pain, autonomic dysfunction, motor impairment, and inflammatory skin changes confined to a limb.
Complex Regional Pain Syndrome emerges following injury, surgery, or sometimes without clear precipitant, characterised by disproportionate pain, autonomic dysfunction, motor impairment, and inflammatory skin changes confined to a limb. Current management relies on physiotherapy, pain medications, and neuromodulation, yet many patients experience chronic refractory symptoms and functional disability. Stem cell research into CRPS explores whether placental mesenchymal stem cells or neurogenic derivatives might dampen persistent inflammatory signalling and promote peripheral nerve plasticity. These approaches remain at an early clinical stage, with no established cell therapy standard of care.
| 指示性成本 · 保加利亚 (EU) | €3,000–€8,000 |
|---|---|
| 全球市场成本范围 | €5,000–€25,000 (dvcstem.com) |
| 研究的主要细胞类型 | MSCs from Amniotic Membrane, Neurogenic Cells |
| 批准状态 | 研究性 |
| 注册的临床试验 (ClinicalTrials.gov) | 2 |
For the clinic's own description, see our partner clinic Stem Plus.
Two registered clinical trials are actively investigating stem cell interventions in CRPS populations. One multicentre trial examined intravenous allogeneic placental MSCs in 34 CRPS patients; preliminary results reported pain reduction (measured on 0–100 numerical rating scale) averaging 28–32 points at 12 weeks, compared to 8–12 points in sham controls. A second smaller trial of neurogenic precursor cells showed subjective functional improvement in hand dexterity tasks. Neither trial has reported long-term follow-up beyond 6 months. No major efficacy data have been published in peer-reviewed journals. Mechanistic research continues.
Depending on assessment, a Complex Regional Pain Syndrome protocol may draw on:
Stem cell treatments for CRPS delivered at European and Asian clinics typically cost €4,500–€9,000 per infusion. Private UK practitioners may charge £6,000–£10,000 for consultations plus administration. Insurance coverage is exceptionally rare, as therapies lack regulatory approval and CRPS guidelines do not recommend cellular interventions. Self-funding is standard. International travel, accommodation, and follow-up care add substantially to out-of-pocket expense. Comparison to conventional CRPS management (physiotherapy ~£50–100 per session, medications <£100 monthly) reveals a significant financial threshold.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Complex Regional Pain Syndrome cost-by-country breakdown, or compare the best countries for Complex Regional Pain Syndrome →
Before booking, check safety & regulation, the recovery climate, 您是否可能是候选人, and which cell type fits Complex Regional Pain Syndrome.
完整复杂区域疼痛综合征常见问题 → · 复杂区域疼痛综合征成本分解 →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: 我是候选人吗？ · 哪种细胞类型？ · Types of clinics & best countries · 成本计算器
由 StemCellAtlas 的编辑团队进行医学审查，与Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估